Horizon Pharma PLC (NASDAQ:HZNP) Short Interest Update

Henrietta Strickland
July 14, 2017

(USNA) has $1.56B valuation. Short shares grew 1,912,650 over that timeframe. About 53,151 shares traded. (NYSE:USNA) has risen 6.87% since July 12, 2016 and is uptrending. Finally, North Tide Capital LLC purchased a new stake in shares of Horizon Pharma PLC during the first quarter valued at about $10,238,000. The Return on Investment (ROI) ratio of Horizon Pharma plc (HZNP) is -2.8 percent. Its up 15.07% from 12.69M shares previously. Cubist Systematic Strategies Limited Com owns 17,635 shares.

About shares traded. Horizon Pharma PLC (NASDAQ:HZNP) has declined 28.13% since July 12, 2016 and is downtrending. It has underperformed by 44.83% the S&P500. Conatus Capital Management Lp, a Connecticut-based fund reported 366,557 shares. The total value of its holdings decreased 1.1%. Its down 0.44, from 1.46 in 2016Q3. It fall, as 40 investors sold HZNP shares while 69 reduced holdings. 44 funds opened positions while 67 raised stakes.

7 analysts on average are expecting the company to report revenue of $255.04 Million for the current quarter. Silvercrest Asset Mgmt Gru Ltd Llc holds 0% or 11,560 shares.

The share of Horizon Pharma plc (HZNP) now has a value of $12.62 while the company's 52 week low is at $9.45, the shares dropped to the 52 week low on 05/10/17.

HZNP's revenue has grown at an average annualized rate of about 169.3% during the past five years. Artal Group Sa stated it has 500,000 shares.

Based on the latest brokerage notes which have been released to investors, 5 brokers have issued a rating of "strong buy", 5 brokers "buy", 2 brokers "neutral", 0 brokers "sell" and 0 brokers "strong sell". Citadel Advsrs Limited Liability Corporation reported 0% stake. Globeflex Lp invested 0.21% of its portfolio in Horizon Pharma PLC (NASDAQ:HZNP). 16,253 are owned by Renaissance Grp Inc Lc. Horizon Pharma PLC had a positive return on equity of 21.51% and a negative net margin of 21.26%. Janney Montgomery Scott Ltd Company reported 0% stake.

Horizon Pharma Public Limited Company (HZNP)'s RSI (Relative Strength Index) is 64.83.

On September 16 the company was changed to a "Market Perform" by Cowen & Co. a cut from the previous "Outperform" rating.

Since February 28, 2017, it had 1 buy, and 1 sale for $414,996 activity.

06/08/2017 - Kite Pharma, Inc. was upgraded to "buy" by analysts at BTIG Research. $509,796 worth of Horizon Pharma PLC (NASDAQ:HZNP) was sold by Carey Robert. On average, analysts forecast that Horizon Pharma PLC will post $0.84 EPS for the current year. Its last month's stock price volatility remained 2.68% which for the week stands at 3.74%. The rating was initiated by BMO Capital Markets on Wednesday, June 29 with "Outperform".

Price targets show what analysts believes a stock will be worth at the end of a certain time period. The stock of Horizon Pharma PLC (NASDAQ:HZNP) earned "Buy" rating by Mizuho on Tuesday, February 28. The company was maintained on Tuesday, June 27 by Stifel Nicolaus. Horizon Pharma PLC has a 52-week low of $9.45 and a 52-week high of $23.44.

10/22/2015 - Horizon Pharma, Inc. had its " rating reiterated by analysts at JMP Securities. FULLER GILBERT A sold $314,455 worth of stock or 4,884 shares. Four equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company's stock. Wal-Mart Stores Inc had 88 analyst reports since August 14, 2015 according to SRatingsIntel. Mizuho maintained the stock with "Buy" rating in Tuesday, November 8 report. The firm earned "Neutral" rating on Thursday, October 15 by Bank of America. They now have a United States dollars 13 price target on the stock. Market Capitalization if basically the market value of the company's shares outstanding.

09/27/2016 - Horizon Pharma, Inc. had its " rating reiterated by analysts at Goldman Sachs. Huntington Bancshares Inc (NASDAQ:HBAN) was raised too.

Investors sentiment increased to 0.8 in Q4 2016. Its down 1.02, from 1.02 in 2016Q3. The ratio analysis is selected to dugout more clear and detail views about firm as a ratio analysis is a quantitative analysis of information contained in a company's financial statements. Nexus Investment holds 2.48% or 211,075 shares in its portfolio. Millennium Mgmt owns 66,569 shares for 0% of their portfolio. Pitcairn Communications accumulated 0.11% or 12,538 shares. Strs Ohio owns 11,200 shares. Blair William Il owns 0% invested in Horizon Pharma PLC (NASDAQ:HZNP) for 20,460 shares. Cornerstone Advsrs owns 84,900 shares for 1.08% of their portfolio. Deutsche Bank & Trust Ag stated it has 249,473 shares or 0% of all its holdings.

The share price of Kite Pharma, Inc. 195,000 are held by Ally. Clinton Group reported 37,557 shares.

Taking notice on volatility measures, price volatility of stock was 2.53% for a week and 3.91% for a month.

Revenue per share is 6.19.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article